Merck KGaA Chosen to Produce Liquid Biopsy Kits
February 18 2020 - 8:52AM
Dow Jones News
By Carlo Martuscelli
Merck KGaA said Tuesday that it has signed a contract to
manufacture liquid biopsy kits for Swedish diagnostics business
Elypta.
The kits will be used to detect biological markers for cancer,
the German company said.
Write to Carlo Martuscelli at carlo.martuscelli@wsj.com;
@carlomartu
(END) Dow Jones Newswires
February 18, 2020 08:37 ET (13:37 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2023 to Apr 2024